HMG (Human Menopausal Gonadotropin).
Combined FSH/LH activity — adjunctive use in HPG-axis recovery and fertility.
Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.
- ✓Magistral preparation — Directive 2001/83/EC Art. 5(1).
- ✓Patient-named prescription only — dispensed against a valid Rx.
- ✓EU-GMP Annex 1 Grade A/B cleanroom compounding.
- ✓Cold-chain shipping across EU/EEA — 2–5 working days.
About HMG (Human Menopausal Gonadotropin).
HMG is purified from the urine of postmenopausal women and contains FSH and LH activity in roughly equal amounts. It has been used in fertility protocols since the 1960s.
Modern protocols often combine HMG with HCG; the FSH activity drives folliculogenesis or spermatogenesis while the LH activity sustains gonadal steroidogenesis.
FSH binds receptors on granulosa cells (ovary) or Sertoli cells (testis), driving folliculogenesis and spermatogenesis respectively. LH binds Leydig and theca cells, driving steroidogenesis.
Intramuscular or subcutaneous injection, doses determined by physician based on individual response and monitoring.
Your physician sets the prescription. This is descriptive information, not a self-administration guide.
Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.
- INN / Name
- HMG (Human Menopausal Gonadotropin)
- Form
- Lyophilised vial · subcutaneous injection
- Strength
- 75IU vial
- Manufacturing
- EU-GMP Annex 1 · Grade A/B
- Endotoxins
- European Pharmacopoeia 2.6.14 · LAL assay
- Identity & purity
- HPLC + MS · > 98%
- Cold chain
- Validated 2–8 °C, monitored end-to-end
- Regulatory basis
- Directive 2001/83/EC · Article 5(1)
2–5 working days
EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.
Magistral preparation
Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.
EU prescription recognition
Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.